Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calcium channel protein type L subunit alpha1C (Cav1.2) is the pore-forming subunit of the voltage-dependent L-type calcium channel. It mediates the influx of calcium ions into cells upon membrane depolarization, playing a crucial role in excitation-contraction coupling in cardiac and smooth muscle, as well as hormone secretion and synaptic transmission. It is a target for dihydropyridine drugs used to treat hypertension and cardiac arrhythmias.
Calcium channel blockade
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium Channel Protein Type L Subunit Alpha1C (Cav1.2).